Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pollack

Showing results (631-640 of 666) with videos related to

Pageof 67
Sort By:
Child Psychiatry and Human Development|June 30, 2017
Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking VeteransAlyson K Zalta, Eric Bui, Niranjan S Karnik, et al.
Molecular Psychiatry|August 12, 2015
Brain connectomics predict response to treatment in social anxiety disorderS Whitfield-Gabrieli, S S Ghosh, A Nieto-Castanon, et al.
Plos One|October 18, 2019
Effect of d-cycloserine on fear extinction training in adults with social anxiety disorderStefan G Hofmann, Santiago Papini, Joseph K Carpenter, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen, Christer Allgulander, Borwin Bandelow, et al.
Depression and Anxiety|May 19, 2021
Sleep quality and outcome of exposure therapy in adults with social anxiety disorderChristina D Dutcher, Sheila M Dowd, Alyson K Zalta, et al.
Behaviour Research and Therapy|April 13, 2016
The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorderAlicia E Meuret, Michael Chmielewski, Ashton M Steele, et al.
Journal of Affective Disorders|April 7, 2020
Improving outcomes for a 3-week intensive treatment program for posttraumatic stress disorder in survivors of military sexual traumaAshton M Lofgreen, Vanessa Tirone, Kathryn K Carroll, et al.
Psychopharmacology|December 22, 2005
Prefrontal and temporal gray matter density decreases in opiate dependenceIn Kyoon Lyoo, Mark H Pollack, Marisa M Silveri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanomaM H Pollack, A Betof, H Dearden, et al.
Journal of Consulting and Clinical Psychology|August 14, 2013
D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variablesJasper A J Smits, Stefan G Hofmann, David Rosenfield, et al.
Pageof 67

Showing results (631-640 of 666) with videos related to

Sort By:
Pageof 67
Child Psychiatry and Human Development|June 30, 2017
Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking VeteransAlyson K Zalta, Eric Bui, Niranjan S Karnik, et al.
Molecular Psychiatry|August 12, 2015
Brain connectomics predict response to treatment in social anxiety disorderS Whitfield-Gabrieli, S S Ghosh, A Nieto-Castanon, et al.
Plos One|October 18, 2019
Effect of d-cycloserine on fear extinction training in adults with social anxiety disorderStefan G Hofmann, Santiago Papini, Joseph K Carpenter, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen, Christer Allgulander, Borwin Bandelow, et al.
Depression and Anxiety|May 19, 2021
Sleep quality and outcome of exposure therapy in adults with social anxiety disorderChristina D Dutcher, Sheila M Dowd, Alyson K Zalta, et al.
Behaviour Research and Therapy|April 13, 2016
The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorderAlicia E Meuret, Michael Chmielewski, Ashton M Steele, et al.
Journal of Affective Disorders|April 7, 2020
Improving outcomes for a 3-week intensive treatment program for posttraumatic stress disorder in survivors of military sexual traumaAshton M Lofgreen, Vanessa Tirone, Kathryn K Carroll, et al.
Psychopharmacology|December 22, 2005
Prefrontal and temporal gray matter density decreases in opiate dependenceIn Kyoon Lyoo, Mark H Pollack, Marisa M Silveri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanomaM H Pollack, A Betof, H Dearden, et al.
Journal of Consulting and Clinical Psychology|August 14, 2013
D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variablesJasper A J Smits, Stefan G Hofmann, David Rosenfield, et al.
Pageof 67